drug

xaluritamig

1 story · latest Jul 30, 2026

Status: Investigational
Code: AMG 509
Trials: 7 registered trials in coverage

Relationships

Developed by Amgen

Timeline

New Phase 2a trial registered for Amgen's xaluritamig after lutetium-177 therapy

Jul 30Trial updateAmgen xaluritamig

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.